Physician profile
Michael Peavey
NPI 1932295995
$9,936.40
in general payments reported to CMS, 2019-2025
29 companies · $320 in 2025
The $320 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,375 · 2020: $238 · 2021: $5,880 · 2022: $1,109 · 2023: $768 · 2024: $248 · 2025: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,116 · Travel and Lodging: $219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,116.24 |
| Travel and Lodging | $218.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,028.44 | 2020-2023 | Da Vinci Surgical System |
| Davol INC. | $1,723.38 | 2020-2025 | Phasix Mesh, Capsure Permanent Fixation System |
| Cook Incorporated | $803.38 | 2019 | |
| Cook Medical LLC | $517.27 | 2019 | |
| Kerecis Limited | $134.65 | 2019-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Vertex Pharmaceuticals Incorporated | $121.61 | 2024-2025 | |
| Smith+Nephew, INC. | $66.25 | 2020-2024 | Pico 14 |
| Organogenesis INC. | $61.27 | 2020 | |
| Sanara Medtech INC. | $56.34 | 2020-2023 | Celleraterx |
| Abbvie INC. | $40.43 | 2024-2025 | |
| Biotissue Holdings INC. | $40.42 | 2025 | |
| Hologic Sales and Service, LLC | $31.62 | 2024 | Localizer |
| Daiichi Sankyo INC. | $29.15 | 2025 | Enhertu |
| Innovation Technologies INC | $26.04 | 2025 | Irrisept |
| Hydrofera LLC | $25.36 | 2023 | Hydrofera Blue |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $24.53 | 2019 | |
| Boston Scientific Corporation | $23.71 | 2022 | |
| Medtronic, INC. | $20.66 | 2025 | Progrip |
| Reprise Biomedical, INC. | $17.30 | 2025 | Miro3d |
| Hologic INC | $16.23 | 2022 | |
| Paratek Pharmaceuticals, INC. | $15.93 | 2024 | Nuzyra |
| Pacira Pharmaceuticals Incorporated | $15.70 | 2025 | Exparel |
| Myriad Genetic Laboratories, INC. | $15.36 | 2021 | |
| Medline Industries LP | $14.72 | 2023 | |
| Convatec INC. | $14.57 | 2023 | |
| Stryker Corporation | $14.27 | 2020 | |
| Ethicon US, LLC | $13.81 | 2025 | Stratafix |
| Covidien LP | $12.48 | 2019 | |
| Integra Lifesciences Corporation | $11.52 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Peavey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.